Accordingly, stratifying CB2 polymorphism on I148M PNPLA3 variant, we have noticed that the effect of R63 CB2 variant on NASH appearance was emphasized in the sub-group of patients carrying the M148 PNPLA3, which is associated to severe steatosis. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatohepatitis.